IB Acquisition to merge with GNQ Insilico, Inc. in a $500M deal
IB Acquisition agreed to merge with GNQ Insilico, Inc., a Health Care company, at a headline value of $500M.
The agreement was announced on Monday 16 March, and we hold no shareholder vote date for it yet.
A $10M PIPE is recorded alongside the deal, though no filing we hold states it, and the combined company is to trade as GNQ.
IBAC dossier The deal 0001493152-26-0346260001493152-26-0102620001493152-26-010261